However, even observed for nearly one month, no significant improvement of GAP-43 was observed with treatment of 20 mg/kg TMP, which may suggest that GAP-43 was not an effective target for TMP on cerebral ischemia reperfusion injury. This evidence concerns the gene GAP43 and Cerebral ischemia.